-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Adaptimmune Therapeutics PLC quarterly/annual Operating Margin history and growth rate from Q4 2017 to Q2 2024.
- Adaptimmune Therapeutics PLC Operating Margin for the quarter ending June 30, 2024 was -54.5 %, a 66% increase year-over-year.
- Adaptimmune Therapeutics PLC annual Operating Margin for 2023 was -232 %, a 61.6% increase from 2022.
- Adaptimmune Therapeutics PLC annual Operating Margin for 2022 was -604 %, a 77.1% increase from 2021.
- Adaptimmune Therapeutics PLC annual Operating Margin for 2021 was -2.64K %, a 21.7% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)